JOHNATHON TUCKER: Open Payments
NPI 1912767674 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,339 in 171 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $3,136 · 2025 $4,339
Food & beverage: $4,260Education: $80
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 19 | $520 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $503 |
| ABBVIE INC. | 29 | $500 |
| Otsuka America Pharmaceutical, Inc. | 14 | $411 |
| Teva Pharmaceuticals USA, Inc. | 16 | $317 |
| Neurocrine BioSciences, Inc. | 8 | $296 |
| Axsome Therapeutics, Inc. | 10 | $286 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $213 |
| Janssen Pharmaceuticals, Inc | 8 | $190 |
| E.R. Squibb & Sons, L.L.C. | 9 | $185 |
Products named: CAPLYTA, VRAYLAR, REXULTI, HETLIOZ, INGREZZA, Auvelity, TRINTELLIX, SPRAVATO.
Industry payments across SC — which companies pay providers there.
